# CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
> **ANDA213530** · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL RX · Approved 2020-10-20
## Drug
- **FDA Application Number:** ANDA213530
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
- **Generic name:** CHLORDIAZEPOXIDE HYDROCHLORIDE AND CLIDINIUM BROMIDE
- **Active ingredients:** CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CHARTWELL RX
- **Manufacturer:** Chartwell RX, LLC
- **First approval:** 2020-10-20
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213530)
---
*AI Analytics · CC0 1.0*